Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systemic therapies for malignant pheochromocytoma and paraganglioma can exacerbate hypertension.

× No keyword cloud information.

5 in total

Review 1. Molecular basis of hypertension side effects induced by sunitinib.

Authors: Guadalupe Aparicio-Gallego; Francisco J Afonso-Afonso; Luis León-Mateos; Jose L Fírvida-Pérez; Sergio Vázquez-Estévez; Martín Lázaro-Quintela; Manuel Ramos-Vázquez; Ovidio Fernández-Calvo; Begoña Campos-Balea; Luis M Antón-Aparicio
Journal: Anticancer Drugs Date: 2011-01 Impact factor: 2.248

2. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

Authors: Montserrat Ayala-Ramirez; Cecile N Chougnet; Mouhammed Amir Habra; J Lynn Palmer; Sophie Leboulleux; Maria E Cabanillas; Caroline Caramella; Pete Anderson; Abir Al Ghuzlan; Steven G Waguespack; Desirée Deandreis; Eric Baudin; Camilo Jimenez
Journal: J Clin Endocrinol Metab Date: 2012-09-10 Impact factor: 5.958

3. Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.

Authors: Yuichi Aita; Kiyo-aki Ishii; Yuria Saito; Tatsuhiko Ikeda; Yasushi Kawakami; Hitoshi Shimano; Hisato Hara; Kazuhiro Takekoshi
Journal: Am J Physiol Endocrinol Metab Date: 2012-08-21 Impact factor: 4.310

4. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

Authors: Sara Gonias; Robert Goldsby; Katherine K Matthay; Randall Hawkins; David Price; John Huberty; Lloyd Damon; Charles Linker; Aimee Sznewajs; Steve Shiboski; Paul Fitzgerald
Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544

5. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors: Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal: Cancer Date: 2008-10-15 Impact factor: 6.921

5 in total